Figure 5.
Figure 5. Chimerism analysis after competitive repopulation assay with Lyl-1–/– and Lyl-1+/+ BM cells. Ly5.2 BM Lyl-1+/+ (wt-5, wt-1, and wt-0.5, respectively) or Lyl-1–/– (KO-5, KO-1, and KO-0.5, respectively) cells (5 × 106, 1 × 106, and 5 × 105) were mixed with 1 × 106 Ly5.1 BM cells and transplanted into lethally irradiated C57B6 Ly5.1 mice. Diagrams represent the percentage of donor-derived cells in PB (A) and BM (B) of reconstituted mice (6 mice per group) at 4 and 24 weeks after injection. An example of 2 independent experiments is shown. Data represent mean ± SEM (*P < .05). The contribution of donor-derived cells to each reconstituted lineage is determined by analyzing the percentage of CD45.2+, B220+; CD45.2+, CD3+; and CD45.2+, GR-1/MAC-1+ cells in PB (C) and in BM (D). Data represent mean ± SEM of 2 independent experiments (*P < .05).

Chimerism analysis after competitive repopulation assay with Lyl-1–/– and Lyl-1+/+ BM cells. Ly5.2 BM Lyl-1+/+ (wt-5, wt-1, and wt-0.5, respectively) or Lyl-1–/– (KO-5, KO-1, and KO-0.5, respectively) cells (5 × 106, 1 × 106, and 5 × 105) were mixed with 1 × 106 Ly5.1 BM cells and transplanted into lethally irradiated C57B6 Ly5.1 mice. Diagrams represent the percentage of donor-derived cells in PB (A) and BM (B) of reconstituted mice (6 mice per group) at 4 and 24 weeks after injection. An example of 2 independent experiments is shown. Data represent mean ± SEM (*P < .05). The contribution of donor-derived cells to each reconstituted lineage is determined by analyzing the percentage of CD45.2+, B220+; CD45.2+, CD3+; and CD45.2+, GR-1/MAC-1+ cells in PB (C) and in BM (D). Data represent mean ± SEM of 2 independent experiments (*P < .05).

Close Modal

or Create an Account

Close Modal
Close Modal